Respiratory syncytial virus: burden, risks, and the way forward-calling for a collaborative approach at World Prematurity Day 2022

Christina Tischer; Johanna Kostenzer; Silke Mader; Luc J I Zimmermann

doi:10.1152/ajplung.00302.2022

Respiratory syncytial virus: burden, risks, and the way forward-calling for a collaborative approach at World Prematurity Day 2022

Am J Physiol Lung Cell Mol Physiol. 2022 Nov 1;323(5):L619-L622. doi: 10.1152/ajplung.00302.2022. Epub 2022 Oct 4.

Authors

Christina Tischer^{1

2}, Johanna Kostenzer¹, Silke Mader¹, Luc J I Zimmermann^{1

3}

Affiliations

¹ European Foundation for the Care of Newborn Infants, Munich, Germany.
² Department of Health Security, Finnish Institute for Health and Welfare, Kuopio, Finland.
³ Department of Paediatrics and Research School for Oncology and Reproduction-GROW, Maastricht UMC+, Maastricht, The Netherlands.

PMID: 36193906
DOI: 10.1152/ajplung.00302.2022

No abstract available

Keywords: Respiratory Syncytial Virus (RSV); World Prematurity Day (WPD); infant and family-centered developmental care (IFCDC); preterm; quality of life.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anti-Bacterial Agents
Drug Resistance, Bacterial
Female
Global Health
Humans
Infant, Newborn
Infant, Premature, Diseases*
Pneumonia*
Premature Birth*
Pulmonary Disease, Chronic Obstructive*
Respiratory Syncytial Virus, Human*

Substances

Anti-Bacterial Agents